Original Article
Antidepressant-like effect of bis-eugenol in the mice forced swimming test: evidence for the involvement of the monoaminergic system
Article first published online: 25 JUL 2012
DOI: 10.1111/j.1472-8206.2012.01058.x
© 2012 The Authors Fundamental and Clinical Pharmacology © 2012 Société Française de Pharmacologie et de Thérapeutique
Issue

Fundamental & Clinical Pharmacology
Early View (Online Version of Record published before inclusion in an issue)
Additional Information
How to Cite
do Amaral, J. F., Silva, M. I. G., de Aquino Neto, M. R., Moura, B. A., de Carvalho, A. M. R., Vasconcelos, P. F., Barbosa Filho, J. M., Gutierrez, S. J. C., Vasconcelos, S. M. M., Macêdo, D. S. and de Sousa, F. C. F. (2012), Antidepressant-like effect of bis-eugenol in the mice forced swimming test: evidence for the involvement of the monoaminergic system. Fundamental & Clinical Pharmacology. doi: 10.1111/j.1472-8206.2012.01058.x
Publication History
- Article first published online: 25 JUL 2012
- Accepted manuscript online: 14 JUN 2012 09:25AM EST
- Manuscript Accepted: 11 JUN 2012
- Manuscript Revised: 19 MAY 2012
- Manuscript Received: 14 SEP 2011
- Abstract
- Article
- References
- Cited By
Keywords:
- antidepressant-like effect;
- bis-eugenol;
- forced swimming test;
- high-performance liquid chromatography;
- monoaminergic system
Abstract
Dehydrodieugenol, known as bis-eugenol, is a eugenol ortho dimer, and both compounds were able to exhibit anti-inflammatory and antioxidant activities in previous studies. Furthermore, eugenol showed antidepressant-like effect; however, the biological actions of bis-eugenol on experimental models for screening antidepressant activity are still unknown. The present study investigated a possible antidepressant-like activity of bis-eugenol in the forced swimming test (FST) and tail suspension test (TST) in mice and the involvement in the monoaminergic system in this effect. In addition, a neurochemical analysis on brain monoamines of mice acutely treated with bis-eugenol was also conducted. Bis-eugenol decreased the immobility time in the FST and TST without accompanying changes in ambulation in the open field test at 10 mg/kg, i.p.. Nevertheless, it induced ambulation at 25 and 50 mg/kg doses. The anti-immobility effect of bis-eugenol (10 and 50 mg/kg, i.p.) was prevented by pretreatment of mice with p-chlorophenylalanine (PCPA, 100 mg/kg, i.p., an inhibitor of serotonin synthesis, for four consecutive days), yohimbine (1 mg/kg, i.p., an α2-adrenoceptor antagonist), SCH23390 (15 μg/kg, s.c., a dopamine D1 receptor antagonist) and sulpiride (50 mg/kg, i.p., a dopamine D2 receptor antagonist). Monoamines analysis using high-performance liquid chromatograph revealed significant increase in the 5-HT, NE and DA levels in brain striatum. The present study indicates that bis-eugenol possesses antidepressant-like activity in FST and TST by altering dopaminergic, serotonergic and noradrenergic systems function.

1472-8206/asset/olbannerleft.gif?v=1&s=5c0825c8c57cb987dbf83f37b85f9a7b97c62dbd)
1472-8206/asset/olbannerright.gif?v=1&s=525488a8904a98c0bd51a2645dea539f90502f02)